186 related articles for article (PubMed ID: 27175823)
1. Thyroid hormone and its metabolites in relation to quality of life in patients treated for differentiated thyroid cancer.
Massolt ET; van der Windt M; Korevaar TI; Kam BL; Burger JW; Franssen GJ; Lehmphul I; Köhrle J; Visser WE; Peeters RP
Clin Endocrinol (Oxf); 2016 Nov; 85(5):781-788. PubMed ID: 27175823
[TBL] [Abstract][Full Text] [Related]
2. Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.
Jonklaas J; Davidson B; Bhagat S; Soldin SJ
JAMA; 2008 Feb; 299(7):769-77. PubMed ID: 18285588
[TBL] [Abstract][Full Text] [Related]
3. Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma.
Lee J; Yun MJ; Nam KH; Chung WY; Soh EY; Park CS
Thyroid; 2010 Feb; 20(2):173-9. PubMed ID: 20151824
[TBL] [Abstract][Full Text] [Related]
4. Decreased sensitivity of thyrotropin-thyroid hormone feedback control in hypothyroid and athyreotic patients treated with levothyroxine. Is serum triiodothyronine involved?
Solter D; Solter M
Ann Endocrinol (Paris); 2018 Apr; 79(2):62-66. PubMed ID: 29530271
[TBL] [Abstract][Full Text] [Related]
5. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
[TBL] [Abstract][Full Text] [Related]
6. Change in Thyroid Hormone Metabolite Concentrations Across Different Thyroid States.
Jongejan RMS; van Velsen EFS; Meima ME; Klein T; van den Berg SAA; Massolt ET; Visser WE; Peeters RP; de Rijke YB
Thyroid; 2022 Feb; 32(2):119-127. PubMed ID: 34806412
[No Abstract] [Full Text] [Related]
7. Effect of Liothyronine Treatment on Quality of Life in Female Hypothyroid Patients With Residual Symptoms on Levothyroxine Therapy: A Randomized Crossover Study.
Bjerkreim BA; Hammerstad SS; Gulseth HL; Berg TJ; Omdal LJ; Lee-Ødegård S; Eriksen EF
Front Endocrinol (Lausanne); 2022; 13():816566. PubMed ID: 35273566
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone indices during illness in six hypothyroid subjects rendered euthyroid with levothyroxine therapy.
Wadwekar D; Kabadi UM
Exp Clin Endocrinol Diabetes; 2004 Jul; 112(7):373-7. PubMed ID: 15239022
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic Relief is Related to Serum Free Triiodothyronine Concentrations during Follow-up in Levothyroxine-Treated Patients with Differentiated Thyroid Cancer.
Larisch R; Midgley JEM; Dietrich JW; Hoermann R
Exp Clin Endocrinol Diabetes; 2018 Sep; 126(9):546-552. PubMed ID: 29396968
[TBL] [Abstract][Full Text] [Related]
10. The different requirement of L-T4 therapy in congenital athyreosis compared with adult-acquired hypothyroidism suggests a persisting thyroid hormone resistance at the hypothalamic-pituitary level.
Bagattini B; Cosmo CD; Montanelli L; Piaggi P; Ciampi M; Agretti P; Marco GD; Vitti P; Tonacchera M
Eur J Endocrinol; 2014 Nov; 171(5):615-21. PubMed ID: 25305309
[TBL] [Abstract][Full Text] [Related]
11. [Effects of various contraceptives on laboratory parameters in diagnosis of thyroid gland function with special reference to the free hormones FT4 and FT3].
Sorger D; Schenk S; Schneider G
Z Gesamte Inn Med; 1992 Feb; 47(2):58-64. PubMed ID: 1585690
[TBL] [Abstract][Full Text] [Related]
12. Thyroid hormone metabolism in thyroid disease as reflected by the ratio of serum triiodothyronine to thyroxine.
Erfurth EM; Hedner P
J Endocrinol Invest; 1986 Oct; 9(5):407-12. PubMed ID: 3794185
[TBL] [Abstract][Full Text] [Related]
13. Changes within the thyroid axis after long-term TSH-suppressive levothyroxine therapy.
Verburg FA; Smit JW; Grelle I; Visser TJ; Peeters RP; Reiners C
Clin Endocrinol (Oxf); 2012 Apr; 76(4):577-81. PubMed ID: 22017394
[TBL] [Abstract][Full Text] [Related]
14. L-thyroxine treatment in primary hypothyroidism does not increase the content of free triiodothyronine in cerebrospinal fluid: a pilot study.
Sjöberg S; Eriksson M; Werner S; Bjellerup P; Nordin C
Scand J Clin Lab Invest; 2011 Feb; 71(1):63-7. PubMed ID: 21214501
[TBL] [Abstract][Full Text] [Related]
15. Sorafenib-induced hypothyroidism is associated with increased type 3 deiodination.
Abdulrahman RM; Verloop H; Hoftijzer H; Verburg E; Hovens GC; Corssmit EP; Reiners C; Gelderblom H; Pereira AM; Kapiteijn E; Romijn JA; Visser TJ; Smit JW
J Clin Endocrinol Metab; 2010 Aug; 95(8):3758-62. PubMed ID: 20484486
[TBL] [Abstract][Full Text] [Related]
16. Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine supplementation therapy.
Crevenna R; Zettinig G; Keilani M; Posch M; Schmidinger M; Pirich C; Nuhr M; Wolzt M; Quittan M; Fialka-Moser V; Dudczak R
Support Care Cancer; 2003 Sep; 11(9):597-603. PubMed ID: 12783288
[TBL] [Abstract][Full Text] [Related]
17. Levothyroxine therapy, calculated deiodinases activity and basal metabolic rate in obese or nonobese patients after total thyroidectomy for differentiated thyroid cancer, results of a retrospective observational study.
Le Moli R; Malandrino P; Russo M; Tumino D; Piticchio T; Naselli A; Rapicavoli V; Belfiore A; Frasca F
Endocrinol Diabetes Metab; 2023 Mar; 6(2):e406. PubMed ID: 36722311
[TBL] [Abstract][Full Text] [Related]
18. Changes in quality of life after thyroidectomy in subjects with thyroid cancer in relation to the dose of levothyroxine.
Monzani ML; Piccinini F; Boselli G; Corleto R; Margiotta G; Peeters RP; Simoni M; Brigante G
J Endocrinol Invest; 2023 Feb; 46(2):319-326. PubMed ID: 35988109
[TBL] [Abstract][Full Text] [Related]
19. Lowering of T3 and rise in reverse T3 induced by hyperglucagonemia: altered thyroid hormone metabolism, not altered release of thyroid hormones.
Kabadi UM; Premachandra BN
Horm Metab Res; 1987 Oct; 19(10):486-9. PubMed ID: 3428867
[TBL] [Abstract][Full Text] [Related]
20. DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 Levels in Thyroid-Deficient Patients.
Castagna MG; Dentice M; Cantara S; Ambrosio R; Maino F; Porcelli T; Marzocchi C; Garbi C; Pacini F; Salvatore D
J Clin Endocrinol Metab; 2017 May; 102(5):1623-1630. PubMed ID: 28324063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
